78358-86-8

Usage

Uses

Used in Pharmaceutical Manufacturing:
1-(2-BROMOETHYL)PYRROLE is used as a key intermediate in the synthesis of numerous pharmaceutical compounds. Its reactivity and versatility make it a valuable component in drug research and development, contributing to the creation of new and improved medications.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(2-BROMOETHYL)PYRROLE is employed as a building block for the assembly of complex organic molecules. Its unique structure and reactivity allow chemists to construct a wide range of compounds with diverse applications.
Used in Medicine:
1-(2-BROMOETHYL)PYRROLE is used as a starting material in the development of new therapeutic agents. Its potential applications in medicine are vast, as it can be incorporated into the design of novel drugs with targeted effects on specific biological pathways or diseases.

InChI:InChI=1/C6H8BrN/c7-3-6-8-4-1-2-5-8/h1-2,4-5H,3,6H2

Upstream product

• 2576-47-8 2-bromoethylamine hydrobromide 
• 34160-24-2 2,5-dimethoxytetrahydrofuran 
• 696-59-3 cis,trans-2,5-dimethoxytetrahydrofuran 
• 107-09-5 2-bromoethylamine 

Relevant academic research and scientific papers

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN

The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II, and methods for treating or preventing or modulating moderate to severe pain in a disease may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of pain, severe pain, chronic pain, chemotherapy induced pain, epilepsy, glaucoma, arthritis, tooth aches, inflammation, musculoskeletal pain, sciatica, radiculopathy pain, migraine, neuropathic pain, post herpetic neuralgia, neuralgia pain, multiple sclerosis, multiple sclerosis, restless legs syndrome (RLS), cluster headache, depression, fibromyalgia, amyotrophic lateral sclerosis (ALS), convulsions, partial seizures, mood-stabilizing agent and bipolar disorder.

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN

The invention relates to the compounds of formula (I) and formula (II) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula (I) or formula (II), and methods for treating or preventing or modulating moderate to severe pain in a disease may be formulated for oral buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of pain, severe pain, chronic pain, chemotherapy induced pain, epilepsy, glaucoma, arthritis, tooth aches, inflammation, musculoskeletal pain, sciatica, radiculopathy pain, migraine, neuropathic pain, post herpetic neuralgia, neuralgia pain, multiple sclerosis, multiple sclerosis, restless legs syndrome (RLS), cluster headache, depression, fibromyalgia, amyotrophic lateral sclerosis (ALS), convulsions, partial seizures, mood-stabilizing agent and bipolar disorder.